NextGen Bio

Found 1,717 articles

• Prevacus Announces Use of blinktbi's EyeStat in Upcoming Phase 1 Clinical Study

  7/13/2018

  Prevacus, Inc. announced a partnership with blinktbi, Inc for use of their patented device, EyeStat, in Prevacus' upcoming Phase 1 clinical research study as an objective biomarker of brain function.

• Oragenics, Inc. Announces Pricing of $12 Million Underwritten Public Offering

  7/13/2018

  Oragenics, Inc. announced the pricing of an underwritten public offering of units for gross proceeds of $12 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company.

• Medical Marijuana Clinic, CannaMD, Expands to Fort Lauderdale, Miami, and West Palm Beach

  7/12/2018

  CannaMD has tripled in size in less than six months.

• Ampio provides a Link to New Publication on the Mechanism of Action for Ampion™

  7/12/2018

  Ampio Pharmaceuticals, Inc. announced a basic science manuscript entitled "The Anti-Inflammatory Effect of LMWF5A and N-Acetyl Kynurenine on Macrophages: Involvement of Aryl Hydrocarbon Receptor in Mechanism of Action" authored by Dr. Bar-Or and prominent clinicians has been published online in Biochemistry and Biophysics Reports.

• DHL in the U.S. Expands Medical Express Service for the Pharmaceutical and Clinical Research Sectors

  7/12/2018

  Introduces enhanced, integrated service between Mexico and the U.S. to meet the unique transportation requirements for urgent pharmaceutical and biomedical shipments

• Convey Health Solutions Achieves HITRUST CSF® Certification to Manage Risk, Improve Security Posture and Meet Compliance Requirements

  7/12/2018

  HITRUST CSF Certification validates Convey Health Solutions is committed to meeting key regulations and protecting sensitive information

• Maxar Technologies Appoints Biggs Porter as Chief Financial Officer

  7/12/2018

  Maxar Technologies announced the appointment of Biggs Porter as Executive Vice President and Chief Financial Officer, effective August 15, 2018.

• Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

  7/12/2018

  SkinCure Provides Turnkey Solution for Sensus' SRT-100 Vision™, Aimed at Dermatology Community

• BioIQ is Humanizing Analytics and Helping Healthcare Organizations Close the Gap Between Data and Performance

  7/12/2018

  BioIQ has announced the advancement of the BioIQ analytics platform.

• St. Jude Children's Research Hospital® honors Dr. James LaVirt Netters Sr.

  7/12/2018

  Icon of the Civil Rights Movement, Distinguished Memphian receives Spirit of ALSAC Award

• American Cancer Society and National Football League Award $3.2 Million in New Grants to Help Reduce Breast Cancer Disparities

  7/12/2018

  Grant funding is supported by the NFL's Crucial Catch campaign

• Dr. Craig Thiessen Joins Singular Medical Technologies Board of Directors

  7/12/2018

  West Houston Radiology Managing Partner Brings Deep Radiology Experience, Health Care Business Acumen

• KromaTiD Inc. Joins the National Institute of Standards and Technology Genome Editing Consortium

  7/11/2018

  KromaTiD, Inc. announced that it has joined the National Institute of Standards and Technology Genome Editing Consortium

• Setting The Record Straight On WHA Resolution

  7/11/2018

  Recent media coverage has turned the World Health Assembly Resolution on Infant and Young Child Feeding into a political debate about breastfeeding vs formula feeding, rather than the public health issue at hand: access to proper information and nutrition education for parents of children up to three years of age.

• Alimera Sciences Announces 8 ILUVIEN® Presentations At The 2018 American Society Of Retina Specialists Annual Meeting

  7/11/2018

  Alimera Sciences, Inc. announced that 8 presentations on ILUVIEN data have been accepted during the 36th Annual Meeting of the American Society of Retina Specialists (ASRS) in Vancouver, BC, Canada, July 20 through 25th.

• Shark Tank Original Member Kevin Harrington Joins Forces with UVLrx Therapeutics, Inc.

  7/11/2018

  Harrington will oversee the marketing and growth trajectory of the company’s multiple-wavelength intravenous light therapy devices

• Diabetes Research Institute Launches New Clinical Trial to Explore Effects of Omega-3 Fatty Acids and Vitamin D in Type 1 Diabetes

  7/11/2018

  Study aims to reduce inflammation, halt autoimmunity, increase insulin sensitivity and secretion in pediatric and adult patients

• Dune Medical Expands Device Portfolio with the Addition of a Reposable Version of MarginProbe

  7/11/2018

  The Reposable MarginProbe, which is used to detect residual cancer during lumpectomy procedures, has received CE Mark approval

• Captozyme Initiates Clinical Study of Nephure™ Oxalate-Reducing Enzyme

  7/11/2018

  ​Study will evaluate Nephure vs. placebo in the reduction of urinary oxalate associated with food

• MediXall Group Announces Partnership to Create MediXall Prescription Discount Program for MediXall.com Users

  7/11/2018

  MediXall Group Inc. is pleased to announce that it has entered into a new partnership with Redwood HCA, LLC to develop a prescription discount program for MediXall users.